Extrait

This trial will compare the efficacy of irinotecan/cisplatin and pemetrexed/cisplatin in the second-line treatment of patients with stage IIIB/IV NSCLC

Critère d'inclusion

• non-small cell lung cancer

Liens

• ictrp
• nct